Table 1.
Characteristics of the Study Population by Mental Diagnosis Category
| Characteristic* | By Mental Diagnosis Category
|
Sig | |
|---|---|---|---|
| Schizophrenia Diagnosis | No Mental Health Disorder | ||
|
| |||
| Race/Ethnicity (N=1,282) | χ2=23.54, p=0.002 | ||
| Non-Hispanic White | 433 of 664 (65%) | 425 of 618 (69%) | |
| Non-Hispanic Black | 114 of 664 (17%) | 82 of 618 (13%) | |
| Asian/PI | 49 of 664 (7%) | 44 of 618 (7 %) | |
| Hispanic | 24 of 664 (4%) | 15 of 618 (2 %) | |
| Other | 44 of 664 (7%) | 52 of 618 (8%) | |
|
| |||
| Age | 55.51 (SD=9.6) | 56.46 (SD=9.4) | t=2.00, p=0.05 |
|
| |||
| Male sex | 316 (44%) | 311 (44%) | χ2=0.06, p=0.83 |
|
| |||
| Medicare | 382 (54%) | 383 (54%) | χ2=0.01, p=0.96 |
|
| |||
| Low neighborhood SES | 104 (15%) | 72 (10%) | χ2=6.51, p=0.01 |
|
| |||
| Body Mass Index (N=865) | χ2=14.39, p=0.001 | ||
| <24.9 | 48 (11%) | 65 (16%) | |
| 25.0–29.9 | 109 (24%) | 129 (31%) | |
| >30.0 | 295 (65%) | 219 (53%) | |
|
| |||
| Uncontrolled Systolic Blood Pressure (N=1,013) | 251 of 542 (46%) | 232 of 471 (49%) | χ2=3.70, p=0.03 |
|
| |||
| Uncontrolled LDL Cholesterol (N=860) | 88 of 459 (19%) | 96 of 401 (24%) | χ2=2.79, p=0.01 |
|
| |||
| Medical comorbidity (Charlson Score) | 1.33 (SD=1.5) | 1.18 (SD=1.6) | t=1.80, p=0.07 |
|
| |||
| Number of medications filled | 7.77 (SD=4.3) | 5.20 (SD=3.6) | t=12.16, p<0.001 |
|
| |||
| Antipsychotic medication use (N=710) | 659 (93%) | - | - |
|
| |||
| Any ER visits, past 6 months | 214 (30%) | 119 (17%) | χ2=36.26, p<0.001 |
|
| |||
| Any Hospitalization, past 6 months | 90 (13%) | 62 (9%) | χ2=6.09, p<0.001 |
|
| |||
| Average Number of outpatient clinic visits, past 6 months | 12.5 (SD=12.0) | 8.8 (SD=13.6) | t=5.63, p<0.001 |
|
| |||
| Statin adherence among users (N=1107) | 350 of 583(60%) | 271 of 524 (52%) | χ2=8.25, p=0.004 |
|
| |||
| ACEI/ARB adherence among users (N=787) | 232 of 383 (61%) | 244 of 404 (60%) | χ2=0.02, p=0.48 |
*
N=1,420 unless otherwise notated.